5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.23▲ | 9.23▲ | 9.24▼ | 8.94▲ | 9.40▼ |
MA10 | 9.23▲ | 9.23▲ | 9.10▲ | 9.01▲ | 9.86▼ |
MA20 | 9.23▲ | 9.09▲ | 8.92▲ | 9.52▼ | 11.43▼ |
MA50 | 9.22▲ | 8.94▲ | 9.02▲ | 10.46▼ | 14.89▼ |
MA100 | 9.13▲ | 9.04▲ | 9.19▲ | 11.88▼ | 17.23▼ |
MA200 | 8.95▲ | 9.25▼ | 9.98▼ | 14.12▼ | 18.83▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.008▲ | 0.056▲ | 0.008▲ | -0.053▼ |
RSI | 51.143▲ | 59.180▲ | 59.882▲ | 44.189▼ | 37.926▼ |
STOCH | 60.087 | 45.229 | 71.644 | 26.796 | 22.020 |
WILL %R | -34.783 | -30.282 | -29.452 | -52.708 | -88.339▼ |
CCI | -70.163 | 23.078 | 63.941 | 3.175 | -94.753 |
Tuesday, July 08, 2025 10:51 PM
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks according to Wall Street analysts. On June 24, Syndax announced that the US FDA granted Priority Review for its ...
|
Tuesday, July 08, 2025 02:18 AM
Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX stock is a Buy.
|
Thursday, June 05, 2025 07:05 AM
Houston-based Stellar Bancorp Inc. (NYSE: STEL) will dual list its stock on NYSE Texas, the New York Stock Exchange’s newly launched fully electronic equities exchange based in Dallas.Stellar ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
09/07/25 | 8.83 | 9.46 | 8.81 | 9.24 | 3,135,810 |
08/07/25 | 8.75 | 8.95 | 8.71 | 8.75 | 1,392,640 |
07/07/25 | 9.14 | 9.14 | 8.585 | 8.73 | 1,584,656 |
03/07/25 | 9.07 | 9.23 | 8.83 | 9.00 | 817,852 |
02/07/25 | 8.80 | 9.495 | 8.77 | 9.00 | 1,789,122 |
01/07/25 | 9.23 | 9.40 | 8.775 | 8.82 | 1,773,667 |
30/06/25 | 9.06 | 9.561 | 8.92 | 9.365 | 2,218,474 |
27/06/25 | 9.34 | 9.40 | 9.01 | 9.04 | 3,244,139 |
26/06/25 | 8.95 | 9.345 | 8.74 | 9.30 | 2,688,841 |
25/06/25 | 9.22 | 9.42 | 8.875 | 8.90 | 1,888,295 |
|
|
||||
|
|
||||
|
|